Global Cataract Devices Market Size By Type (IOLs, OVDs), By Application (Ophthalmology Centers, Hospitals), By Region, And Segment Forecasts, 2023 to 2032

The Global Cataract Devices Market was valued at USD 9.8 billion in 2023 and is projected to reach USD 15.6 billion by 2031, growing at a CAGR of 6.1% during the forecast period of 2023-2031. The rising prevalence of cataracts, increasing geriatric population, and advancements in ophthalmic surgical technologies are driving market growth. Cataract devices, including intraocular lenses (IOLs), phacoemulsification equipment, and femtosecond lasers, are witnessing high demand due to their role in improving visual outcomes and enhancing patient quality of life.

Drivers

Rising Prevalence of Cataracts

The increasing incidence of cataracts, primarily due to aging populations and prolonged exposure to UV radiation, is a key driver. According to WHO, cataracts are the leading cause of blindness globally, prompting the demand for effective surgical solutions.

Technological Advancements in Cataract Surgery

Innovations such as femtosecond laser-assisted cataract surgery (FLACS), premium intraocular lenses (IOLs), and AI-driven surgical planning are enhancing surgical precision, reducing complications, and improving patient outcomes.

Expanding Access to Eye Care Services

Government initiatives and healthcare reforms aimed at improving access to cataract surgery, particularly in developing nations, are driving the adoption of cataract devices. Programs like VISION 2020: The Right to Sight are boosting investments in ophthalmic care.

Restraints

High Cost of Advanced Cataract Devices

The cost of premium IOLs, femtosecond lasers, and phacoemulsification systems can be a significant barrier, particularly in low- and middle-income countries. Limited reimbursement policies also restrict the widespread adoption of advanced cataract treatment technologies.

Shortage of Skilled Ophthalmic Surgeons

Despite advancements in surgical techniques, a lack of trained ophthalmologists in rural and underserved areas hinders access to cataract treatment, affecting market penetration in these regions.

Opportunity

Growing Demand for Premium Intraocular Lenses (IOLs)

The shift toward multifocal and toric IOLs for better post-surgical vision correction presents a lucrative opportunity. These lenses eliminate dependence on glasses, enhancing patient satisfaction.

Market Expansion in Emerging Economies

Countries such as India, China, Brazil, and Indonesia are witnessing increased healthcare spending and improved infrastructure for cataract treatment, creating opportunities for market players.

Integration of AI and Robotics in Cataract Surgery

The adoption of AI-powered diagnostic tools and robotic-assisted surgeries in ophthalmology is expected to streamline cataract treatment, offering higher precision and improved efficiency.

Market by Product Insights

Intraocular Lenses (IOLs) Segment Dominates

The Intraocular Lenses (IOLs) segment accounted for the largest market share in 2023. Monofocal IOLs continue to be the most widely used due to their affordability and insurance coverage. However, premium IOLs (multifocal, extended depth-of-focus, and toric lenses) are gaining popularity due to their ability to correct presbyopia and astigmatism.

Phacoemulsification Devices Witnessing Significant Growth

The phacoemulsification devices segment is expected to witness significant growth, driven by the increasing adoption of minimally invasive cataract surgeries. The femtosecond laser-assisted surgery (FLACS) sub-segment is also expanding due to its advantages in reducing phaco energy usage and enhancing precision.

Market by End-use Insights

Hospitals Leading the Market

Hospitals dominated the cataract devices market in 2023, holding over 40% of the market share. The availability of advanced surgical infrastructure, specialized ophthalmic care units, and high patient footfall contribute to the segment’s growth.

Ambulatory Surgical Centers (ASCs) Gaining Traction

ASCs are witnessing rapid adoption due to cost-effectiveness, shorter recovery times, and increasing outpatient procedures. Many ophthalmic surgeries are shifting to ASCs due to their efficiency and ability to provide quality care at a lower cost.

Market by Regional Insights

North America Holds the Largest Market Share

North America led the global cataract devices market in 2023, driven by the high adoption of advanced surgical procedures, strong healthcare infrastructure, and a large aging population.

Asia-Pacific Poised for Rapid Growth

Asia-Pacific is expected to witness the highest CAGR during the forecast period, fueled by:

Rising cataract cases due to an aging population

Government-led cataract awareness and surgical programs

Increasing healthcare spending and medical tourism in India, China, and Japan

Europe Also a Significant Contributor

Europe remains a significant market, with strong government funding for ophthalmology and high awareness about cataract surgeries. Countries like Germany, France, and the UK are major contributors.

Competitive Scenario

Key players operating in the Global Cataract Devices Market include:

Alcon Inc.

Johnson & Johnson Vision

Bausch + Lomb

Carl Zeiss Meditec AG

Hoya Corporation

Nidek Co., Ltd.

Rayner Intraocular Lenses Limited

Oertli Instrumente AG

STAAR Surgical Company

Topcon Corporation

These companies focus on product innovations, strategic mergers & acquisitions, and global expansion to strengthen their market position.

Key Market Developments:

In 2023, Alcon Inc. launched a new advanced trifocal intraocular lens, improving post-cataract visual outcomes.

In 2022, Johnson & Johnson Vision introduced a next-generation phacoemulsification system, enhancing surgical efficiency.

In 2024, Carl Zeiss Meditec AG partnered with leading ophthalmic clinics to integrate AI-driven cataract diagnostics and planning solutions.

Scope of Work – Global Cataract Devices Market

Report Metric Details

Market Size (2023) USD 9.8 billion

Projected Market Size (2031) USD 15.6 billion

CAGR (2023-2031) 6.1%

Key Segments By Product Type (Intraocular Lenses, Phacoemulsification Devices, Femtosecond Laser Systems), By End-use (Hospitals, Ambulatory Surgical Centers, Specialty Clinics)

Growth Drivers Rising Cataract Prevalence, Technological Advancements, Expanding Access to Eye Care

Opportunities Premium IOL Demand, AI & Robotics Integration, Emerging Markets Expansion

FAQs

1. What is the current market size of the Global Cataract Devices Market?

The market was valued at USD 9.8 billion in 2023 and is projected to reach USD 15.6 billion by 2031.

2. What is the major growth driver of the Cataract Devices Market?

The market is driven by the rising prevalence of cataracts, increasing adoption of advanced surgical technologies, and expanding access to cataract treatment globally.

3. Which region is expected to witness the highest growth in the Cataract Devices Market?

Asia-Pacific is expected to witness the highest CAGR, driven by an aging population, government-led eye care programs, and increasing healthcare investments.

4. Which product segment accounted for the largest market share in the Cataract Devices Market?

The Intraocular Lenses (IOLs) segment accounted for the largest market share in 2023, with premium IOLs experiencing rapid adoption.

5. Who are the key players in the Cataract Devices Market?

Major players include Alcon Inc., Johnson & Johnson Vision, Bausch + Lomb, Carl Zeiss Meditec AG, Hoya Corporation, and Nidek Co., Ltd., among others.

This structured and SEO-friendly market report description provides a comprehensive, engaging, and data-driven overview of the Global Cataract Devices Market for investors, stakeholders, and industry professionals. 🚀